Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, First in Human Study to Evaluate the Feasibility of the SENTANTE Robotic System Application in Peripheral Endovascular Interventions

NCT06537947 is registered in ClinicalTrials.gov with Inovatyvi Medicina UAB as lead sponsor.

NCT NCT06537947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06537947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, First in Human Study to Evaluate the Feasibility of the SENTANTE Robotic System Application in Peripheral Endovascular Interventions
Lead sponsor
Inovatyvi Medicina UAB
Phase
Not applicable
Overall status
Completed
Start date
July 19, 2024
Completion date
October 30, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

any disease which requires peripheral endovascular intervention